-
Single-step purification of a bacterially expressed antibody Fv fragment by immobilized metal affinity chromatography in the presence of betaine.
J Chromatogr A. 1993 Dec 24;657(1):55-61
PMID: 8111478
-
CD30L-ETA': a new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphoma.
Cytokines Cell Mol Ther. 1999 Jun;5(2):69-78
PMID: 10515679
-
Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display.
Appl Biochem Biotechnol. 1994 May-Jun;47(2-3):157-71; discussion 171-3
PMID: 7944335
-
Purification and characterization of recombinant pea-seed ferritins expressed in Escherichia coli: influence of N-terminus deletions on protein solubility and core formation in vitro.
Biochem J. 1995 Jan 1;305 ( Pt 1):253-61
PMID: 7826338
-
Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).
Int J Cancer. 1995 Feb 8;60(4):539-44
PMID: 7530238
-
Cloning, expression and characterization of the Fv fragments of the anti-carbohydrate mAbs B1 and B5 as single-chain immunotoxins.
Protein Eng. 1994 Dec;7(12):1509-15
PMID: 7716163
-
Osmoadaptation in bacteria.
Adv Microb Physiol. 1995;37:272-328
PMID: 8540423
-
Back to log phase: sigma S as a global regulator in the osmotic control of gene expression in Escherichia coli.
Mol Microbiol. 1996 Sep;21(5):887-93
PMID: 8885260
-
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines.
Cytokines Mol Ther. 1996 Sep;2(3):139-46
PMID: 9384698
-
Diabodies: small bispecific antibody fragments.
Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):128-30
PMID: 9435855
-
Clinical applications of immunotoxins. Introduction.
Curr Top Microbiol Immunol. 1998;234:1-11
PMID: 9670609
-
Microbial water stress.
Bacteriol Rev. 1976 Dec;40(4):803-46
PMID: 1008746
-
Cellular location affects protein stability in Escherichia coli.
Proc Natl Acad Sci U S A. 1982 Mar;79(6):1830-3
PMID: 7043465
-
Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa.
Infect Immun. 1984 May;44(2):262-7
PMID: 6425217
-
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.
J Mol Biol. 1986 May 5;189(1):113-30
PMID: 3537305
-
New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues.
J Chromatogr. 1987 Dec 18;411:177-84
PMID: 3443622
-
High efficiency transformation of E. coli by high voltage electroporation.
Nucleic Acids Res. 1988 Jul 11;16(13):6127-45
PMID: 3041370
-
Heat-shock proteins DnaK and GroEL facilitate export of LacZ hybrid proteins in E. coli.
Nature. 1990 Apr 26;344(6269):882-4
PMID: 2109835
-
Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice.
Int J Cancer. 1991 Sep 30;49(3):450-6
PMID: 1917143
-
Recombinant toxins for cancer treatment.
Science. 1991 Nov 22;254(5035):1173-7
PMID: 1683495
-
A novel strategy for production of a highly expressed recombinant protein in an active form.
FEBS Lett. 1991 Dec 16;295(1-3):10-2
PMID: 1765138
-
Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease.
Cell. 1992 Feb 7;68(3):421-7
PMID: 1310894
-
Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells.
J Immunol Methods. 1992 Mar 4;147(2):153-65
PMID: 1548398
-
Degradation of secreted proteins in Escherichia coli.
Ann N Y Acad Sci. 1992 Oct 13;665:301-8
PMID: 1416612
-
Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor.
Cancer Res. 1992 Nov 15;52(22):6310-7
PMID: 1358432
-
A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies.
Anal Biochem. 1992 Sep;205(2):263-70
PMID: 1332541
-
Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised mice.
Ann Oncol. 1992 Sep;3 Suppl 4:21-3
PMID: 1450076
-
Building antibodies from their genes.
Immunol Rev. 1992 Dec;130:41-68
PMID: 1286871
-
Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice.
J Exp Med. 1993 May 1;177(5):1257-68
PMID: 8386741
-
Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines.
Int J Mol Med. 1998 Jan;1(1):249-56
PMID: 9852227
-
Oxidative refolding chromatography: folding of the scorpion toxin Cn5.
Nat Biotechnol. 1999 Feb;17(2):187-91
PMID: 10052357
-
A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins.
Gene. 1999 Mar 18;229(1-2):145-53
PMID: 10095114
-
An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Br J Cancer. 1999 Jun;80(8):1214-22
PMID: 10376974
-
Extrinsic protein stabilization by the naturally occurring osmolytes beta-hydroxyectoine and betaine.
Extremophiles. 1999 Aug;3(3):191-8
PMID: 10484175
-
Recombinant toxins.
Adv Pharmacol. 1994;28:193-219
PMID: 8080817